Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening
- PMID: 26294105
- DOI: 10.1136/bjophthalmol-2015-306958
Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening
Abstract
Background/aims: Optic nerve tortuosity and nerve and sheath thickening are observed on MRI in some patients with neurofibromatosis type 1 (NF-1). This study aimed to determine if tortuosity and thickening are associated with the development of optic pathway glioma (OPG) and subsequent vision loss.
Methods: Children with NF-1 who underwent brain MRI between 1992 and 2005, and had at least 1 year of subsequent visual acuity (VA) follow-up, were identified retrospectively. The baseline MRI was independently reviewed by three neuroradiologists for consensus assessment. Tortuosity was identified using validated operational criteria. Optic nerve and sheath thicknesses and VA at last follow-up were directly measured.
Results: Of 132 evaluable children, seven (5%) had tortuosity on baseline MRI. 20 subjects (15%) ultimately developed OPG at a median of 1.9 years (range 7 months-8.0 years) following the baseline MRI. Subjects with tortuosity were significantly more likely to develop OPG than those without tortuosity (57% vs 13%, p=0.01). In subjects who developed OPG, the prevalence of tumour-related vision loss was not significantly different between those with and without baseline tortuosity (14% vs 4%, p=0.28). No difference existed between mean baseline optic nerve (2.3 vs 2.2 mm) or sheath (5.2 vs 5.4 mm) thicknesses comparing subjects who did and did not develop OPG.
Conclusions: Optic nerve tortuosity at baseline is associated with OPG development among patients with NF-1, but does not predispose to aggressive OPG with associated vision loss. Neither nerve nor sheath thickening at baseline is associated with OPG development.
Keywords: Imaging; Neoplasia; Optic Nerve; Vision; Visual pathway.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2895-902. doi: 10.1167/iovs.06-0429. Invest Ophthalmol Vis Sci. 2007. PMID: 17525226
-
Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?J AAPOS. 2006 Aug;10(4):307-11. doi: 10.1016/j.jaapos.2006.02.004. J AAPOS. 2006. PMID: 16935228
-
Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit.Eye (Lond). 2010 Oct;24(10):1603-5. doi: 10.1038/eye.2010.99. Epub 2010 Aug 6. Eye (Lond). 2010. PMID: 20689568
-
Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.Ann Neurol. 2007 Mar;61(3):189-98. doi: 10.1002/ana.21107. Ann Neurol. 2007. PMID: 17387725 Free PMC article. Review.
-
Optic pathway glioma of childhood.Curr Opin Ophthalmol. 2017 May;28(3):289-295. doi: 10.1097/ICU.0000000000000370. Curr Opin Ophthalmol. 2017. PMID: 28257299 Review.
Cited by
-
Neurofibromatosis Type 1 Presenting with Ophthalmic Features: A Case Series.J Clin Diagn Res. 2016 Nov;10(11):SR01-SR03. doi: 10.7860/JCDR/2016/21041.8780. Epub 2016 Nov 1. J Clin Diagn Res. 2016. PMID: 28050470 Free PMC article.
-
Predicting pediatric optic pathway glioma progression using advanced magnetic resonance image analysis and machine learning.Neurooncol Adv. 2020 Aug 1;2(1):vdaa090. doi: 10.1093/noajnl/vdaa090. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32885166 Free PMC article.
-
Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype-Phenotype Correlations in A Large Independent Cohort.Cancers (Basel). 2019 Nov 21;11(12):1838. doi: 10.3390/cancers11121838. Cancers (Basel). 2019. PMID: 31766501 Free PMC article.
-
Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.Neurology. 2016 Jun 14;86(24):2264-70. doi: 10.1212/WNL.0000000000002771. Epub 2016 May 11. Neurology. 2016. PMID: 27170570 Free PMC article.
-
Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI.Turk J Med Sci. 2019 Dec 16;49(6):1626-1633. doi: 10.3906/sag-1906-14. Turk J Med Sci. 2019. PMID: 31655505 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous